The largest community of pharma leaders

Sensorion: Reporting of the General Assembly Appointment of Three New Directors

MONTPELLIER, France–(BUSINESS WIRE)–Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biopharmaceutical company which specialises in the development of novel therapies to restore, treat and prevent inner ear diseases such as hearing loss, tinnitus and vertigo held its combined general meeting on July 29, 2019. The Combined Ordinary and Extraordinary General Shareholders’ Meeting, held in Paris on July 29, 2019, under the chairmanship of Nawal Ouzren, adopted the resolutions submitt … 

Recent Articles